Jan 26, 2009 | Laboratory Pathology, Management & Operations
Wall Street has yet to grasp this essential truth of laboratory medicine-lab test quality comes with its own price tag At this moment in time, Quest Diagnostics Incorporated’s (NYSE:DGX) advertised value proposition to other labs—”industry-leading quality and technical proficiency”—has diminished credibility with pathologists and lab industry executives. They are questioning how the nation’s largest lab company could allow systemic errors that caused it to report...
Dec 4, 2008 | Laboratory News, Laboratory Pathology
California is often a national leader for innovations in managed care contracting, as well as new approaches for delivering healthcare. So when your Dark Daily editor visited the laboratory at the UCLA Medical Center this week, he was quite curious about the ways in which clinical laboratory testing and anatomic pathology services are being used at this respected national academic center. For one thing, UCLA has recently moved into a brand new hospital building. The Ronald Reagan Medical...
Oct 24, 2008 | Laboratory Management and Operations, Laboratory Pathology
Use of antibodies that detect biomarkers in as little as 15 minutes now allows researchers at the University of Leeds in the United Kingdom to identify such diseases as prostate and ovarian cancer, stroke, multiple sclerosis (MS), heart disease, and fungal infections. Using biosensors to identify the molecular markers for disease, the technology is much faster than current testing methods. One goal of this research is to provide a way for hospitals to use this technology for rapid diagnosis....
